Replies to post #30757 on Ayala Pharmaceuticals Inc (ADXS)

[exel_mm]

If there is any significant licensing deals, there will be 2 waves of affect:

Wave 1: Initial bump to specific deal
Wave 2: Extended, deep runup after the market consumes the realization that Advaxis is a diverse multi-construct delivery platform

Wave 2 will be unbelievable.

[JB-22]

Presentation will only be on mono no combo per Noelle. Doesn't mean Merck hasn't seen what is going on though. This leads me to believe the mono should be good due to the fact they were awarded poster pres..